Join us for an insightful webinar exploring Lonza’s comprehensive portfolio of primary human cells and optimized media systems. Discover how these foundational tools empower researchers to develop advanced, complex in vitro models that deliver improved biological relevancy and predictive power. Lonza scientists will guide attendees through applications in angiogenesis research, from simple qualitative screening approaches to sophisticated co-culture models enabling precise quantitative analysis.

In the second half of the session, our collaborator Aracari Biosciences will present their cutting-edge vascularized organ and tumor chips. These innovative platforms offer physiologically relevant environments that accelerate drug development by providing more accurate and meaningful results.

Whether you're advancing disease modeling or optimizing drug screening, this webinar will provide valuable insights into building more predictive and translational in vitro systems.

• Receive an introduction to how primary cells can be utilized for optimized screening and testing


• Learn how biologically-relevant and predictive models can be built using the co-culture of primary cells


• Gain insight regarding the importance of vascularization in 3D models and how to
  achieve it